AMMONAPS 940 mg/g, granules bottle, 266 g
Active ingredients: Sodium phenylbutyrate
Commercialized according to BDPMDispensing in France: Prescription only
Granulesbottle, 266 gorale
No current ANSM shortage notice is included
Package details
Original BDPM fields are shown in French.
- Official name
- AMMONAPS 940 mg/g, granulés
- Pharmaceutical form
- granulés
- Route of administration
- orale
- Presentation description
- 1 flacon(s) polyéthylène haute densité (PEHD) de 266 g avec fermeture de sécurité enfant avec cuillère-mesure
- Marketing authorisation holder
- IMMEDICA PHARMA (SUEDE)
- Reimbursement according to BDPM
- —
- Approval for use in healthcare institutions
- non
- Commercialization declaration date
- 30 Jun 2023
- Prescription and dispensing conditions
- Prescription only
- List I: prescription-only medicine
- Prescribed by a hospital doctor
- Enhanced ANSM monitoring
- No
BDPM identifiers
CIS
60052254CIP75628329CIP133400956283293Composition in BDPM
| Component | Amount per unit | Source type |
|---|---|---|
| SODIUM (PHÉNYLBUTYRATE DE)granulés | 940 mg · 1 g de granulés | SA |
Information is based on BDPM data and is for reference only. Consult a doctor before use.
Similar medicines
Similar medicines are listed using the official BDPM catalog. Availability must be checked separately. Consult a doctor or pharmacist before switching medicines.
The current BDPM data does not list similar medicines for this product.